007570 — Ilyang Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Market Cap
KR₩234bn
Enterprise Value
KR₩341bn
Revenue
KR₩371bn

Annual balance sheet for Ilyang Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	35,896	41,610	81,924	64,825	18,883
Net Total Accounts Receivable
Net Total Receivables	69,476	64,945	69,518	67,595	69,004
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	171,407	162,496	203,560	200,728	159,066
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	182,047	185,671	197,309	198,019	198,628
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	437,456	439,117	494,271	498,185	459,456
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	180,329	177,147	198,210	186,859	173,674
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	240,558	231,923	270,157	263,532	232,499
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	196,898	207,194	224,115	234,654	226,957
Total Liabilities & Shareholders' Equity	437,456	439,117	494,271	498,185	459,456
Total Common Shares Outstanding
Total Preferred Shares Outstanding